Epidemiological and clinical characteristics of children with peripheral neuroblastic tumors: a study on a Moroccan population

被引:3
作者
Eddaibouni, Aroua Anissi [1 ]
Guebessi, Nisrine Bennani [1 ]
Cherkaoui, Siham [1 ]
Karkouri, Mehdi [1 ]
Khoubila, Nisrine [1 ]
Maataoui-Belabbes, Hajar [2 ]
机构
[1] Hassan II Univ, Fac Med & Pharm, Cellular & Mol Pathol Lab, Casablanca, Morocco
[2] Hosp 20 August, Hematol & Pediat Oncol Dept, Casablanca, Morocco
关键词
Peripheral neuroblastic tumors; Neuroblastoma; Heterogeneity; Metastatic; Epidemiology;
D O I
10.1007/s00432-023-05502-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PurposePeripheral neuroblastic tumors are the most common extracranial cancers found in children, and they are characterized by a diverse spectrum of clinical manifestations and heterogeneous behaviors. This study aimed to investigate the epidemiological and clinical characteristics of children with peripheral neuroblastic tumors admitted to the Department of Pediatric Hematology and Oncology of the Hospital August 20 in Casablanca.MethodsThe medical files of 48 children with peripheral neuroblastic tumors addressed to our department between February 2018 and February 2023 were reviewed. The clinical and demographic characteristics of patients were analyzed by the Statistical Package for the Social Sciences (SPSS), survival curves were obtained by Kaplan-Meier technique, and we assigned the tumor stage to patients based on the International Neuroblastoma Risk Group Staging System (INRGSS).ResultsThe median age of diagnosis was 30 months (1-174), with a ratio F/M of 1.28. 93.75% of patients had neuroblastoma, and the rest had ganglioneuroma. About 64.6% of patients had at their initial presentations stage M of peripheral neuroblastic tumors. The adrenal region made up 71% of the primary tumor site. The bone was one of the most prevalent metastatic sites (54.2%). The five-year overall survival rate was 35.4%.ConclusionOverall, this study revealed a high stage of peripheral neuroblastic tumors in the majority of the diagnosed patients in our Department of Pediatric Hematology and Oncology. Moreover, the heterogeneity of peripheral neuroblastic tumors makes clinical recognition difficult and, in general, too late.
引用
收藏
页码:18029 / 18037
页数:9
相关论文
共 18 条
[1]  
Bordbar MR, 2014, IRAN J PEDIATR HEMAT, V4, P89
[2]   Clinical and biological features prognostic of survival after relapse or progression of INRGSS stage MS pattern neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project [J].
Campbell, Kevin ;
Kao, Pei-Chi ;
Naranjo, Arlene ;
Kamijo, Takehiko ;
Ramanujachar, Ramya ;
London, Wendy B. ;
DuBois, Steven G. .
PEDIATRIC BLOOD & CANCER, 2023, 70 (02)
[3]  
Colon Nadja C, 2011, Adv Pediatr, V58, P297, DOI 10.1016/j.yapd.2011.03.011
[4]   Tumoral heterogeneity in neuroblastoma [J].
Gomez, Roshna Lawrence ;
Ibragimova, Shakhzada ;
Ramachandran, Revathy ;
Philpott, Anna ;
Ali, Fahad R. .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2022, 1877 (06)
[5]   Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group [J].
Irwin, Meredith S. ;
Naranjo, Arlene ;
Zhang, Fan F. ;
Cohn, Susan L. ;
London, Wendy B. ;
Gastier-Foster, Julie M. ;
Ramirez, Nilsa C. ;
Pfau, Ruthann ;
Reshmi, Shalini ;
Wagner, Elizabeth ;
Nuchtern, Jed ;
Asgharzadeh, Shahab ;
Shimada, Hiroyuki ;
Maris, John M. ;
Bagatell, Rochelle ;
Park, Julie R. ;
Hogarty, Michael D. .
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (29) :3229-2021
[6]   Epidemiological and some clinical characteristics of neuroblastoma in Mexican children (1996-2005) [J].
Juarez-Ocana, Servando ;
Palma-Padilla, Virginia ;
Gonzalez-Miranda, Guadalupe ;
Georgina Siordia-Reyes, Alicia ;
Lopez-Aguilar, Enrique ;
Aguilar-Martinez, Martha ;
Manuel Mejia-Arangure, Juan ;
Carreon-Cruz, Rogelio ;
Enrique Rendon-Macias, Mario ;
Fajardo-Gutierrez, Arturo .
BMC CANCER, 2009, 9
[7]  
Lucena Januária Nunes, 2018, Rev. paul. pediatr., V36, P254, DOI 10.1590/1984-0462/
[8]  
2018
[9]  
36
[10]  
3